These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1845468)

  • 1. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 5: Normolipidemic (latent) dyslipoproteinemia.
    Choluj B
    Acta Univ Carol Med (Praha); 1991; 37(3-4):141-55. PubMed ID: 1845468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atheroslcerosis. Part I: Principles of classification and methods of dyslipoproteinemia determination.
    Choluj B; Votruba T; Kormúth E
    Acta Univ Carol Med (Praha); 1991; 37(3-4):91-105. PubMed ID: 1845469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 3: Hypertriacylglycerolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):116-28. PubMed ID: 1845466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in blood lipid levels after the lipid tolerance test in patients with vascular diseases].
    Miti L; Sprovieri G; Breschi L; Foschi F
    Minerva Med; 1975 Oct; 66(65):3406-27. PubMed ID: 1178134
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):129-40. PubMed ID: 1845467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperlipidemia and decrease of lipid tolerance as factors of atherogenesis].
    Ambroskina VV; Kriachok TA; Larionov OP; Talaieva TV; Bratus' VV
    Fiziol Zh (1994); 2007; 53(6):19-28. PubMed ID: 18309627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma lipoproteins in humans: metabolism and relation to atherosclerosis].
    Seidel D
    Z Kardiol; 1984; 73 Suppl 2():23-8. PubMed ID: 6528700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid metabolism disorders in chronic kidney failure].
    Lacour B; Roullet JB; Drueke T
    Nephrologie; 1983; 4(2):75-83. PubMed ID: 6348572
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic lipase, lipoprotein metabolism, and atherogenesis.
    Santamarina-Fojo S; González-Navarro H; Freeman L; Wagner E; Nong Z
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1750-4. PubMed ID: 15284087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipids and atherosclerosis].
    González Santos P; De la Higuera Rojas J
    Rev Clin Esp; 1974 Mar; 132(5):387-98. PubMed ID: 4208680
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemias.
    Glueck CJ; Speirs J; Tracy T
    J Lab Clin Med; 1990 May; 115(5):603-9. PubMed ID: 2341762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The exocrine pancreas in metabolic diseases].
    Herfort K; Skrha F; Sobra J; Heyrovsky A
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(1):3-10. PubMed ID: 4655084
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperlipidemia (possible role of various enzyme deficiencies)].
    Warembourg H; Biserte G; Jaillard J; Sézille G; Bertrand M
    Lille Med; 1968 Nov; 13(9):1010-20. PubMed ID: 5741667
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dynamics of blood lipid levels in urban inhabitants].
    Mustafina OE; Tuktarova IA; Nafikova VA; Rafikov KhS
    Med Tr Prom Ekol; 1996; (1):16-20. PubMed ID: 8673367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics].
    Mudríková T; Tkác I; Takác M
    Vnitr Lek; 1994 Apr; 40(4):250-4. PubMed ID: 8184588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein lipase activity and blood lipid fractions in hypertension].
    Bozadzhieva E; Radeva S; Chankova P; Rusinov E; Danev I
    Vutr Boles; 1973; 12(1):45-50. PubMed ID: 4711401
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the relation between pulmonary emphysema (evaluated by various spirometric parameters) and lipid metabolism indicators in the blood. II].
    Miłkowski A; Miłkowska E; Kieć E; Spett K
    Przegl Lek; 1983; 40(5):439-42. PubMed ID: 6622744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some changes in lipid metabolism in atherosclerotic patients following treatment with vitamins B 1, B 6, and B 12].
    Sokolov IM
    Vopr Pitan; 1969; 28(3):17-21. PubMed ID: 5370140
    [No Abstract]   [Full Text] [Related]  

  • 20. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P
    Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.